Figure 2
From: Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan
Rate of SVR12 stratified by different treatment durations (a), or combinations of previous treatment history and liver cirrhosis status (b) (TE, treatment experienced; TN, treatment naïve; CC, compensated cirrhosis; NC, non-cirrhotic).
